|
Phase 3 trial of pembrolizumab as a first-line treatment in subjects with recurrent/metastatic head and neck squamous cell carcinoma: KEYNOTE-048 |
|
|
|
Titel: |
Phase 3 trial of pembrolizumab as a first-line treatment in subjects with recurrent/metastatic head and neck squamous cell carcinoma: KEYNOTE-048 |
Auteur: |
Klochikhin, A. Greil, R. Cohen, E. Vermorken, J. Harrington, K. Tahara, M. Ge, J.Y. Geib, J. Jin, F. Burtness, B. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 26 () nr. S8 pagina's viii5 |
Jaar: |
2015 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|